PA8537101A1 - HISTAMINE RECEIVER ANTAGONISTS - Google Patents
HISTAMINE RECEIVER ANTAGONISTSInfo
- Publication number
- PA8537101A1 PA8537101A1 PA20028537101A PA8537101A PA8537101A1 PA 8537101 A1 PA8537101 A1 PA 8537101A1 PA 20028537101 A PA20028537101 A PA 20028537101A PA 8537101 A PA8537101 A PA 8537101A PA 8537101 A1 PA8537101 A1 PA 8537101A1
- Authority
- PA
- Panama
- Prior art keywords
- histamine
- histamine receiver
- receiver antagonists
- antagonist
- antagonists
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Otolaryngology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
LA PRESENTA INVENCION PROPORCIONA UNA COMBINACION DE (a) UN ANTAGONISTA DE RECEPTOR H1 DE HISTAMINA Y (b) UN ANTAGONISTA QUE ES AL MENOS 10 VECES MAS SELECTIVO PARA EL RECEPTOR F4 DE HISTAMINA EN COMPARACION CON EL RECEPTOR H3 DE HISTAMNA; Y UN ANTAGONISTA QUE ES AL MENOS 10 VECES MAS SELECTIVO PARA EL RECEPTOR H4 DE HISTAMINA EN COMPARACION CON EL RECEPTOR H3 DE HISTAMINA; Y SUS COMPOSICIONES Y USOS.THE PRESENT INVENTION PROVIDES A COMBINATION OF (a) A H1 HISTAMINE RECEIVER ANTAGONIST AND (b) AN ANTAGONIST THAT IS AT LEAST 10 TIMES MORE SELECTIVE FOR THE H4 HISTAMINE RECEIVER COMPARED TO THE H3 HISTAMINE RECEIVER; AND AN ANTAGONIST THAT IS AT LEAST 10 TIMES MORE SELECTIVE FOR H4 HISTAMINE RECEIVER COMPARED TO HISTAMINE RECEIVER H3; AND ITS COMPOSITIONS AND USES.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0101223.6A GB0101223D0 (en) | 2001-01-17 | 2001-01-17 | Histamine receptor antagonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PA8537101A1 true PA8537101A1 (en) | 2002-08-29 |
Family
ID=9906993
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PA20028537101A PA8537101A1 (en) | 2001-01-17 | 2002-01-14 | HISTAMINE RECEIVER ANTAGONISTS |
Country Status (31)
| Country | Link |
|---|---|
| EP (1) | EP1353657A1 (en) |
| JP (1) | JP2004517883A (en) |
| KR (1) | KR20030069216A (en) |
| CN (1) | CN1486178A (en) |
| AP (1) | AP2002002401A0 (en) |
| AR (1) | AR032101A1 (en) |
| BG (1) | BG107834A (en) |
| BR (1) | BR0206502A (en) |
| CA (1) | CA2435121A1 (en) |
| CR (1) | CR6983A (en) |
| CZ (1) | CZ20031853A3 (en) |
| DO (1) | DOP2002000325A (en) |
| EA (1) | EA200300537A1 (en) |
| EC (1) | ECSP034692A (en) |
| EE (1) | EE200300335A (en) |
| GB (1) | GB0101223D0 (en) |
| GT (1) | GT200200003A (en) |
| HU (1) | HUP0302767A2 (en) |
| IL (1) | IL156087A0 (en) |
| IS (1) | IS6818A (en) |
| MA (1) | MA26980A1 (en) |
| MX (1) | MXPA03006408A (en) |
| NO (1) | NO20033223L (en) |
| OA (1) | OA12440A (en) |
| PA (1) | PA8537101A1 (en) |
| PL (1) | PL362793A1 (en) |
| SK (1) | SK8572003A3 (en) |
| SV (1) | SV2003000849A (en) |
| TN (1) | TNSN02003A1 (en) |
| WO (1) | WO2002056871A2 (en) |
| ZA (1) | ZA200304180B (en) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030133931A1 (en) * | 2001-12-21 | 2003-07-17 | Robin Thurmond | Use of histamine H4 receptor antagonist for the treatment of inflammatory responses |
| WO2004021999A2 (en) * | 2002-09-06 | 2004-03-18 | Janssen Pharmaceutica, N.V. | Use of histamine h4 receptor modulators for the treatment of allergy and asthma |
| US20050090527A1 (en) * | 2003-01-28 | 2005-04-28 | Schering Corporation | Combination of H1, H3 and H4 receptor antagonists for treatment of allergic and non-allergic pulmonary inflammation, congestion and allergic rhinitis |
| US8236786B2 (en) * | 2008-08-07 | 2012-08-07 | Pulmagen Therapeutics (Inflammation) Limited | Respiratory disease treatment |
| WO2013151982A1 (en) | 2012-04-03 | 2013-10-10 | Arena Pharmaceuticals, Inc. | Methods and compounds useful in treating pruritus, and methods for identifying such compounds |
| EP3378476A1 (en) | 2012-06-08 | 2018-09-26 | Sensorion | H4 receptor inhibitors for treating tinnitus |
-
2001
- 2001-01-17 GB GBGB0101223.6A patent/GB0101223D0/en not_active Ceased
-
2002
- 2002-01-10 OA OA1200300174A patent/OA12440A/en unknown
- 2002-01-10 SK SK857-2003A patent/SK8572003A3/en unknown
- 2002-01-10 EE EEP200300335A patent/EE200300335A/en unknown
- 2002-01-10 CN CNA028036840A patent/CN1486178A/en active Pending
- 2002-01-10 IL IL15608702A patent/IL156087A0/en unknown
- 2002-01-10 MX MXPA03006408A patent/MXPA03006408A/en unknown
- 2002-01-10 PL PL02362793A patent/PL362793A1/en not_active Application Discontinuation
- 2002-01-10 EA EA200300537A patent/EA200300537A1/en unknown
- 2002-01-10 CZ CZ20031853A patent/CZ20031853A3/en unknown
- 2002-01-10 BR BR0206502-9A patent/BR0206502A/en not_active IP Right Cessation
- 2002-01-10 WO PCT/IB2002/000042 patent/WO2002056871A2/en not_active Application Discontinuation
- 2002-01-10 CA CA002435121A patent/CA2435121A1/en not_active Abandoned
- 2002-01-10 EP EP02732099A patent/EP1353657A1/en not_active Withdrawn
- 2002-01-10 HU HU0302767A patent/HUP0302767A2/en unknown
- 2002-01-10 KR KR10-2003-7009493A patent/KR20030069216A/en not_active Application Discontinuation
- 2002-01-10 JP JP2002557379A patent/JP2004517883A/en not_active Withdrawn
- 2002-01-11 DO DO2002000325A patent/DOP2002000325A/en unknown
- 2002-01-14 PA PA20028537101A patent/PA8537101A1/en unknown
- 2002-01-16 TN TNTNSN02003A patent/TNSN02003A1/en unknown
- 2002-01-16 SV SV2002000849A patent/SV2003000849A/en not_active Application Discontinuation
- 2002-01-16 AR ARP020100145A patent/AR032101A1/en not_active Application Discontinuation
- 2002-01-16 GT GT200200003A patent/GT200200003A/en unknown
- 2002-01-17 AP APAP/P/2002/002401A patent/AP2002002401A0/en unknown
-
2003
- 2003-05-15 IS IS6818A patent/IS6818A/en unknown
- 2003-05-21 BG BG107834A patent/BG107834A/en unknown
- 2003-05-22 CR CR6983A patent/CR6983A/en not_active Application Discontinuation
- 2003-05-29 ZA ZA200304180A patent/ZA200304180B/en unknown
- 2003-07-11 MA MA27233A patent/MA26980A1/en unknown
- 2003-07-16 NO NO20033223A patent/NO20033223L/en not_active Application Discontinuation
- 2003-07-17 EC EC2003004692A patent/ECSP034692A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BR0206502A (en) | 2003-10-21 |
| SV2003000849A (en) | 2003-01-13 |
| NO20033223D0 (en) | 2003-07-16 |
| TNSN02003A1 (en) | 2005-12-23 |
| PL362793A1 (en) | 2004-11-02 |
| HUP0302767A2 (en) | 2003-11-28 |
| OA12440A (en) | 2006-05-22 |
| EA200300537A1 (en) | 2004-02-26 |
| EP1353657A1 (en) | 2003-10-22 |
| ECSP034692A (en) | 2003-08-29 |
| EE200300335A (en) | 2003-12-15 |
| GB0101223D0 (en) | 2001-02-28 |
| MXPA03006408A (en) | 2003-10-15 |
| CR6983A (en) | 2003-11-25 |
| ZA200304180B (en) | 2004-06-15 |
| CN1486178A (en) | 2004-03-31 |
| JP2004517883A (en) | 2004-06-17 |
| NO20033223L (en) | 2003-07-16 |
| IL156087A0 (en) | 2003-12-23 |
| BG107834A (en) | 2004-01-30 |
| GT200200003A (en) | 2002-08-19 |
| CA2435121A1 (en) | 2002-07-25 |
| AP2002002401A0 (en) | 2002-03-31 |
| IS6818A (en) | 2003-05-15 |
| KR20030069216A (en) | 2003-08-25 |
| AR032101A1 (en) | 2003-10-22 |
| SK8572003A3 (en) | 2004-07-07 |
| CZ20031853A3 (en) | 2004-07-14 |
| DOP2002000325A (en) | 2003-01-31 |
| WO2002056871A2 (en) | 2002-07-25 |
| MA26980A1 (en) | 2004-12-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PA8567001A1 (en) | ZIPRASIDONE COMPOSITION AND SYNTHETIC CONTROLS | |
| HN2002000299A (en) | DERIVATIVES OF 3- AZABICICLO [3.1.0] HEXANO | |
| DE69532162D1 (en) | Cannabinoid receptor Antagonist | |
| DK1379239T3 (en) | N (2-aryl-ethyl) -benzylamines as antagonists of the HT6 receptor | |
| PT1305286E (en) | CYCLOPENTANOINDOLES COMPOSITIONS CONTAINING THE REFERRED COMPOUNDS AND METHODS OF TREATMENT | |
| NO20033424D0 (en) | 3,4-Disubstituted Cyclobutene-1,2-Diones as CXC Chemokine Receptor Antagonists | |
| PA8527201A1 (en) | CYCLED PEPTIDES WITH AGONIST ACTIVITY FOR THE RECEIVER OF MELANOCORTIN-4 (MC4-R) | |
| EE200300524A (en) | Compounds that are CB2 Receptor Agonists, Pharmaceutical Compositions Containing Them, and Therapeutic Use of the Compounds | |
| BR0015963A (en) | Muscarinic receptor antagonist urea compounds, pharmaceutical compositions comprising such compounds and method of preparing these compounds | |
| PT1328269E (en) | ASSOCIATE OF AN ANTAGONIST OF THE CB1 RECEPTOR AND SIBUTRAMINE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND USES FOR THE TREATMENT OF OBESITY | |
| EE200300246A (en) | EP4 receptor selective agonists for the treatment of osteoporosis | |
| AR028505A1 (en) | USE OF AN ANTAGONIST OF THE CENTRAL CANNABINOID RECEPTORS FOR THE PREPARATION OF USEFUL MEDICINES TO MAKE IT MORE LIKELY TO STOP TOBACCO CONSUMPTION | |
| BR0206595A (en) | Compound, pharmaceutical composition, and use of a compound | |
| PA8452701A1 (en) | PROSTAGLANDIN AGONISTS | |
| MXPA03010158A (en) | Sulfonamides. | |
| MY135916A (en) | Use of certain affinity nmda antagonists as antidepressants | |
| ECSP034531A (en) | SUBSTITUTED DERIVATIVES OF C-CICLOHEXILMETILAMINA | |
| PA8537101A1 (en) | HISTAMINE RECEIVER ANTAGONISTS | |
| UY26627A1 (en) | IL-8 RECEPTOR ANTAGONISTS | |
| ECSP034532A (en) | DERIVATIVES OF 1-AMINOBUTAN-3-OL REPLACED | |
| ES2155187T3 (en) | BICYCLE ANTAGONISTS OF TAQUICINAS, PREPARATION OF THESE ANTAGONISTS AND ITS USE IN PHARMACEUTICAL COMPOUNDS. | |
| UY27124A1 (en) | HISTAMINE RECEIVER ANTAGONISTS | |
| NO20000518L (en) | 2-acylaminopropanamines as tachykinin receptor antagonists | |
| DK1420789T3 (en) | Use of active substances with myopioid receptor agonist and opioid receptor antagonist effect as combination drugs for cancer treatment | |
| HN2002000356A (en) | PHARMACEUTICAL COMBINATION |